
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 86220-42-0 |
| Catalog No. | 2A-3175146 |
| Chinese Name | 醋酸萘法瑞林 |
| Synonyms | nafarelin acetate hydrate; nafarelin acetate; MFCD00895733 |
| Molecular Formula | C68H89N17O16 |
| Molecular Weight | 1322.47 (anhydrous free base basis) |
| Purity | ≥95 (HPLC) |
| Boiling Point | 1840.1ºC at 760 mmHg |
| Appearance | solid |
| Storage Condition | 2-8°C, sealed, dry |
| PubChem ID | 329818673 |
| MDL Number | MFCD00895733 |
| SMILES | O.CC(O)=O.CC(C)C[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](Cc6cnc[nH]6)NC(=O)[C@@H]7CCC(=O)N7)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N8CCC[C@H]8C(=O)NCC(N)=O |
| InChI | 1S/C66H83N17O13.C2H4O2.H2O/c1-36(2)25-48(58(89)76-47(13-7-23-71-66(68)69)65(96)83-24-8-14-54(83)64(95)73-33-55(67)86)77-60(91)50(28-38-15-18-39-9-3-4-10-40(39)26-38)78-59(90)49(27-37-16-19-43(85)20-17-37)79-63(94)53(34-84)82-61(92)51(29-41-31-72-45-12-6-5-11-44(41)45)80-62(93)52(30-42-32-70-35-74-42)81-57(88)46-21-22-56(87)75-46;1-2(3)4;/h3-6,9-12,15-20,26,31-32,35-36,46-54,72,84-85H,7-8,13-14,21-25,27-30,33-34H2,1-2H3,(H2,67,86)(H,70,74)(H,73,95)(H,75,87)(H,76,89)(H,77,91)(H,78,90)(H,79,94)(H,80,93)(H,81,88)(H,82,92)(H4,68,69,71);1H3,(H,3,4);1H2/t46-,47-,48-,49-,50+,51-,52-,53-,54-;;/m0../s1 |
| InChI Key | FSBTYDWUUWLHBD-UDXTWCDOSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| Hazard Symbols | transportation |
| MSDS | msds/175561_1_86220_42_0.pdf |
| Use of | Nafarelin is a gonadotropin-releasing hormone agonist (GnRH agonist) which acts as an analog of GnRH. Nafarelin increases the release of FSH and LH by the anterior pituitary, which in turn leads to an increase of estrogen/progesterone. When administered, Nafarelin has the purpose of causing increase estrogen that will negatively feed back upon hypothalamus to decrease GnRH ( negative feedback loop ) Through negative feedback, Nafarelin causes a decrease in pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Nafarelin may be used in the treatment of estrogen-dependent conditions (such as endometriosis or uterine fibroids), to treat central precocious puberty, and to control ovarian stimulation in IVF. It is normally delivered via a nasal spray. Nafarelin acetate is marketed by Searle (now part of Pfizer) under the brand name Synarel. Properties Articles27 Name 5-oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-3-(2-naphthyl)-d-alanyl-l-leucyl-l-arginyl-l-prolylglycinamide acetate hydrate Synonym More Synonyms Chemical & Physical Properties Molecular Formula C68H89N17O16 Exact Mass 1399.67000 PSA 518.66000 LogP 3.89850 InChIKey FSBTYDWUUWLHBD-UDXTWCDOSA-N |
| Transport Info | Product name: Purity: 98.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: No dangerous goods IMDG Code: No dangerous goods International Air Transport Dangerous Regulations: No dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special precautions for users No data available The company is not responsible for any damage caused by any operation or contact with the above products. For more terms of use, see invoice or package The reverse side of the mounting strip. |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Myristoyl Hexapeptide-4 | 959610-44-7 | 2A-3175139 |
| Myristoyl Hexapeptide-23 | 2A-3175140 | 2A-3175140 |
| KGF | 148348-15-6 | 2A-3175141 |
| Promote the stem cell growth factor | 2A-3175142 | 2A-3175142 |
| Romurtide | 78113-36-7 | 2A-3175145 |
| Histrelin Acetate | 220810-26-4 | 2A-3175147 |
| Thymodepressin OR Orilotimod | 186087-26-3 | 2A-3175148 |
| Pentetreotide | 138661-02-6 | 2A-3175149 |
| Carperitide | 89213-87-6 | 2A-3175150 |
| Glatiramer Acetate | 28704-27-0 | 2A-3175151 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA